Renin-angiotensin system inhibition reverses the altered triacylglycerol metabolic network in diabetic kidney disease.
Kelli M SasJiahe LinChih-Hong WangHongyu ZhangJharna SahaThekkelnaycke M RajendiranTanu SoniViji NairFelix EichingerMatthias KretzlerFrank C BrosiusGeorge MichailidisSubramaniam PennathurPublished in: Metabolomics : Official journal of the Metabolomic Society (2021)
In addition to the known salutary effect of RAS inhibition on DKD progression, our results suggest a previously unrecognized role for RAS inhibition on the kidney triacylglycerol lipid metabolic network.
Keyphrases